Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.6409
+0.1047 (19.53%)
Jun 26, 2025, 12:19 PM - Market open

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $21.27 million as of June 26, 2025. Its market cap has decreased by -76.80% in one year.

Market Cap
21.27M
Enterprise Value
-9.26M
1-Year Change
-76.80%
Ranking
Category
Stock Price
$0.64

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has decreased from $56.60M to $21.27M, a decrease of -62.42%. That is a compound annual growth rate of -9.56%.

History

DateMarket Cap% Change
Jun 24, 202519.60M24.84%
Dec 31, 202415.70M-87.40%
Dec 29, 2023124.60M18.67%
Dec 30, 2022105.00M-73.42%
Dec 31, 2021395.00M-24.17%
Dec 31, 2020520.90M30.00%
Dec 31, 2019400.70M1,125.38%
Dec 31, 201832.70M247.87%
Dec 29, 20179.40M-28.24%
Dec 30, 201613.10M-54.67%
Dec 31, 201528.90M-48.94%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 691.83B
Johnson & Johnson 364.09B
AbbVie 324.59B
Novo Nordisk 309.67B
UnitedHealth Group 272.76B
Abbott Laboratories 231.85B
Novartis AG 229.25B
AstraZeneca 218.15B
Market Cap Rankings